TE_21193
Basic information Differential Expression Stage analysis Survival analysis Correlation analysis| TE family | MER50 |
|---|---|
| TE superfamily | ERV1 |
| TE class | LTR |
| Gene | - |
| Class | Intergenic |
| Coding | Non-coding |
| Tumor-specific score | 219.78 |
| Counts of samples | TCGA_tumor:194; TCGA_normal:0; GTEx:0 |
| TSS | chr10(+):18777485 |
Transcript isoforms
| Transcript_ID | Gene | Class | Coding | ORF | Position |
|---|---|---|---|---|---|
| teRNA_21193.1 | - | Intergenic | Non-coding | Non-coding | chr10(+):18777486,18777530,18778292,18778364,18778476,18778584,18836170,18836232,18836398,18836418 |
| teRNA_21193.2 | - | Intergenic | Non-coding | Non-coding | chr10(+):18777486,18777530,18778292,18778364,18778476,18778584,18808192,18808212 |
| teRNA_21193.3 | - | Intergenic | Non-coding | Non-coding | chr10(+):18777486,18777530,18778292,18778364,18778476,18778584,18802663,18802683 |
| teRNA_21193.4 | - | Intergenic | Non-coding | Non-coding | chr10(+):18777486,18777530,18778292,18778364,18778476,18778584,18789603,18789623 |
| teRNA_21193.5 | - | Intergenic | Non-coding | Non-coding | chr10(+):18777486,18777530,18778292,18778364,18778476,18778584,18789603,18789711,18802663,18802683 |
| teRNA_21193.6 | - | Intergenic | Non-coding | Non-coding | chr10(+):18777486,18777530,18778292,18778364,18778476,18778584,18831643,18831663 |
| teRNA_21193.7 | - | Intergenic | Non-coding | Non-coding | chr10(+):18777486,18777530,18778292,18778364,18778476,18778584,18789603,18789711,18836170,18836232,18836398,18836418 |
| teRNA_21193.8 | - | Intergenic | Non-coding | Non-coding | chr10(+):18777486,18777530,18778292,18778364,18778476,18778584,18834265,18834285 |
| teRNA_21193.9 | - | Intergenic | Non-coding | Non-coding | chr10(+):18777486,18777530,18778292,18778364,18778476,18778584,18794291,18794311 |
| teRNA_21193.10 | - | Intergenic | Non-coding | Non-coding | chr10(+):18777486,18777530,18778292,18778364,18778476,18778584,18814737,18814757 |
1
2
GTEx
The proportion of samples in which the TE-initiated transcript was expressed across 46 body sites in the Genotype-Tissue Expression (GTEx) project.
TCGA
The proportion of samples in which the TE-initiated transcript was expressed across 33 cancer types from The Cancer Genome Atlas (TCGA).
GTEx
The expression of TE-initiated transcript across 46 body sites from The Genotype-Tissue Expression (GTEx) project.
